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Increased free radical formation and altered redox 
state are of fundamental importance in the pathogenesis 
of autoimmune diseases including Systemic Lupus 
Erythematos (SLE). Free radicals are mainly derived 
from oxygen (Reactive Oxygen Species/ROS) and 
nitrogen (Reactive Nitrogen Species/RNS) at 
mitochondria, cellular membranes and the endoplasmic 
reticulum membrane as physiological responses to a 
variety of internal and external stress (Shah et al., 
2011b). At low levels, they act as signalling molecules 
and at high levels, they damage organelles, particularly 
the mitochondria and causes irreversible damage to 
lipids, DNA and proteins, thus provoking cell death 
through several modes, including apoptosis and necrosis 
(Shah et al., 2013). In the last 2 decades, there has been 
substantial progress in understanding the mechanism of 
oxidative stress in pathogenesisof SLE and level of 
intracellular glutathione has been regarded as a 
checkpoint of oxidative stress (Shah et al., 2014). 
Altered signal transduction; mTOR is activated by 
relative depletion of glutathione and supplementation of 
N-Acetyl Cysteine (NAC), a precursor of glutathione, 
replenishs intracellular glutathione and inhibitsmTOR 
signaling and diminished oxidative stress mediated 
damage in SLE (Fernandez and Perl, 2010). 
Management of disease through supplement of NAC 
andrapamycin has been showing promising therapy in 
SLE patients. Recently, several lines of evidence from 
genetic, cell biology and lupus animal model studies 
suggests a pivotal role of autophagy in mediating the 
occurrence and development of SLE (Alessandri et al., 
2012). Interestingly, autophagy is regulated by mTOR 
pathway and mTOR is activated by relative depletion of 
glutathione. Thus, redox signaling may provide a link 
between altered autophagy and depletion of glutathione 
and autophagy regulation by replenishment of 
intracellular glutathione may have a therapeutic 
intervention for the management of disease. 
We have shown that changes in the intracellular 
redox environment of cells, through oxygen-derived free 
radical production known as oxidative stress, have been 
reported to be critical for cellular immune dysfunction 
(Shah et al., 2010), activation of apoptotic enzymes and 
apoptosis (Shah et al., 2013). Decreased intracellular 
glutathione levels in the various blood components, 
including total lymphocytes and its subsets (CD4, CD8 T 
cell) are strongly associated with disease severity and 
linked to increase Th1/Th2 cytokine imbalance and 
lymphocyte apoptosis in SLE patients (Shah et al., 
2011a). Similarly, Tewthanom et al. (2009) reported that 
administration of NAC may be beneficial in mild SLE 
patients in terms of decreasing lipid peroxidation. 
Lai et al. (2012) demonstrates that GSH regulates the 
elevation of mitochondrial transmembrane potential 
(∆ψm) or Mitochondrial Hyperpolarization (MHP), 
which in turn activates the mammalian Target Of 
Rapamycin (mTOR) in lupus T cells. mTOR skews cell 
death signal processing, modulates T-cell 
differentiation and, in particular, inhibits the 
development of CD4+/CD25+/Foxp3+ regulatory T 
cells which are deficient in patients with active SLE. 
Nevertheless, studies of Fernandez and Perl (2010; 
Lai et al., 2012) are certainly important as they 
suggest the blockade of mTOR with rapamycin and 
NACimproves lupus disease activity. 
Over recent years, perturbation in autophagy has been 
implicated in a number of diseases, including systemic 
lupus erythematosus (Alessandri et al., 2012). Towns et al. 
(2005) found that serum factors, likely autoantibodies, 
purified from patients with SLE were able to induce 
autophagy in neuroblastoma cell lines, providing a further 
link between autophagy and SLE. Accordingly, several 
other groups have reported the activated autophagy 
pathway in T and B lymphocytes as a mechanism for 
survival of autoreactive T and B lymphocytes. The 
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inhibition of autophagy by blocking mTORsgnalling has 
been suggested as a novel treatment target in this disease. 
Importantly, Lai et al. (2012) has shown that 
blockade of mTOR with supplementation of NAC 
reversing glutathione depletion and improving disease 
activity and fatigue in patients with SLE. NAC treatment 
promotes expansion of CD4+CD25+FOXP3+ T-cell 
subsets, inhibit anti-DNA antibody production. Indeed, 
NAC reversed the expansion of CD4–CD8– T cells, 
which exhibited the most prominent mTOR activation 
before treatment with NAC and had been deemed 
responsible for promoting anti-DNA autoantibody 
production by B cells. They showed that NACacts as a 
sensor of ∆Ψm, mTOR governs T-cell signalling events 
implicated in the pathogenesis (Lai et al., 2012). Since, 
activation of autophagy has been considered to be 
principally regulated by mTOR pathway and 
supplementation of NAC block mTOR signalling in SLE 
patients. It will be intriguing to study the effect of 
therapeutic supplement of NAC on autophagy in animal 
models of Lupus and in SLE patients. Such kind of studies 
encourage to explore more therapeutic potential of NAC 
which might prove to provide an inexpensive and 
significant alternative therapy in SLE.  
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